These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31927791)

  • 1. The aberrant expression of rhythm genes affects the genome instability and regulates the cancer immunity in pan-cancer.
    Zhou J; Li X; Zhang M; Gong J; Li Q; Shan B; Wang T; Zhang L; Zheng T; Li X
    Cancer Med; 2020 Mar; 9(5):1818-1829. PubMed ID: 31927791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer.
    Cao R; Yang F; Ma SC; Liu L; Zhao Y; Li Y; Wu DH; Wang T; Lu WJ; Cai WJ; Zhu HB; Guo XJ; Lu YW; Kuang JJ; Huan WJ; Tang WM; Huang K; Huang J; Yao J; Dong ZY
    Theranostics; 2020; 10(24):11080-11091. PubMed ID: 33042271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity.
    Ge Y; Wei F; Du G; Fei G; Li W; Li X; Chu J; Wei P
    BMC Cancer; 2021 Mar; 21(1):240. PubMed ID: 33678158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers.
    Wu HX; Chen YX; Wang ZX; Zhao Q; He MM; Wang YN; Wang F; Xu RH
    J Immunother Cancer; 2019 Oct; 7(1):264. PubMed ID: 31623662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors.
    Akagi K; Oki E; Taniguchi H; Nakatani K; Aoki D; Kuwata T; Yoshino T
    Cancer Sci; 2021 Mar; 112(3):1105-1113. PubMed ID: 33403729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Damage and Repair Biomarkers of Immunotherapy Response.
    Mouw KW; Goldberg MS; Konstantinopoulos PA; D'Andrea AD
    Cancer Discov; 2017 Jul; 7(7):675-693. PubMed ID: 28630051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?
    Chen X; Jiang Z; Wang Z; Jiang Z
    Aging (Albany NY); 2021 May; 13(9):12849-12864. PubMed ID: 33946045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment.
    Caracciolo D; Riillo C; Arbitrio M; Di Martino MT; Tagliaferri P; Tassone P
    Int J Cancer; 2020 Nov; 147(10):2658-2668. PubMed ID: 32383203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
    Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
    BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
    Wen WX; Leong CO
    PLoS One; 2019; 14(4):e0215381. PubMed ID: 31022191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.
    Takeda K; Nakayama M; Hayakawa Y; Kojima Y; Ikeda H; Imai N; Ogasawara K; Okumura K; Thomas DM; Smyth MJ
    Nat Commun; 2017 Feb; 8():14607. PubMed ID: 28233863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma.
    Tiffen J; Gallagher SJ; Filipp F; Gunatilake D; Emran AA; Cullinane C; Dutton-Register K; Aoude L; Hayward N; Chatterjee A; Rodger EJ; Eccles MR; Hersey P
    J Invest Dermatol; 2020 Dec; 140(12):2442-2454.e5. PubMed ID: 32360600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
    Lv J; Zhu Y; Ji A; Zhang Q; Liao G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32239176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics modulates the complexity of the response to Immune Checkpoint Blockade.
    Barragan I
    EBioMedicine; 2020 Oct; 60():103005. PubMed ID: 32987318
    [No Abstract]   [Full Text] [Related]  

  • 16. HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.
    Zeng H; Song X; Ji J; Chen L; Liao Q; Ma X
    BMC Cancer; 2020 Aug; 20(1):796. PubMed ID: 32831060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
    Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
    Xie F; Zhang J; Wang J; Reuben A; Xu W; Yi X; Varn FS; Ye Y; Cheng J; Yu M; Wang Y; Liu Y; Xie M; Du P; Ma K; Ma X; Zhou P; Yang S; Chen Y; Wang G; Xia X; Liao Z; Heymach JV; Wistuba II; Futreal PA; Ye K; Cheng C; Xia T
    Clin Cancer Res; 2020 Jun; 26(12):2908-2920. PubMed ID: 31911545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.
    Liu JN; Kong XS; Sun P; Wang R; Li W; Chen QF
    J Cell Mol Med; 2021 Feb; 25(4):2082-2097. PubMed ID: 33373169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARID1A deficiency and immune checkpoint blockade therapy: From mechanisms to clinical application.
    Hu G; Tu W; Yang L; Peng G; Yang L
    Cancer Lett; 2020 Mar; 473():148-155. PubMed ID: 31911080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.